Welcome to LookChem.com Sign In|Join Free

CAS

  • or

132628-16-1

Post Buying Request

132628-16-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132628-16-1 Usage

Description

N2-Phenylacetyl guanosine is a modified nucleoside derivative of guanosine, characterized by the attachment of a phenylacetyl group to the nitrogen-2 position of the guanine base. This chemical modification confers enhanced stability and selectivity to the compound, positioning it as a valuable asset in nucleic acid research and as a prospective therapeutic agent.

Uses

Used in Pharmaceutical Research:
N2-Phenylacetyl guanosine is utilized as a research tool for its potential to inhibit viral replication, making it a candidate for the development of antiviral therapies. Its ability to interfere with the life cycle of viruses could lead to the creation of new treatments for viral infections.
Used in Anticancer Applications:
In the field of oncology, N2-Phenylacetyl guanosine is employed as an anti-cancer agent, demonstrating promising results in preclinical studies. Its potential to target and disrupt cancer cell processes could contribute to the development of novel cancer therapies.
Used in Nucleoside Analog Development:
N2-Phenylacetyl guanosine is used as a starting point for the development of nucleoside analogs for RNA and DNA modification. This application is crucial for the advancement of nucleic acid-based technologies, potentially leading to innovative approaches in genetic research and gene therapy.
Used in Biochemical and Molecular Biology Research:
As a modified nucleoside, N2-Phenylacetyl guanosine is used in biochemical and molecular biology research to study the interactions of nucleic acids with proteins and other biomolecules, providing insights into the fundamental mechanisms of genetic information processing.

Check Digit Verification of cas no

The CAS Registry Mumber 132628-16-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,6,2 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 132628-16:
(8*1)+(7*3)+(6*2)+(5*6)+(4*2)+(3*8)+(2*1)+(1*6)=111
111 % 10 = 1
So 132628-16-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H19N5O6/c24-7-10-13(26)14(27)17(29-10)23-8-19-12-15(23)21-18(22-16(12)28)20-11(25)6-9-4-2-1-3-5-9/h1-5,8,10,13-14,17,24,26-27H,6-7H2,(H2,20,21,22,25,28)/t10-,13-,14-,17-/m1/s1

132628-16-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide

1.2 Other means of identification

Product number -
Other names N-(Phenylacetyl)guanosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:132628-16-1 SDS

132628-16-1Downstream Products

132628-16-1Relevant articles and documents

Preparation N 2-phenylacetyl-D-guanylin improved method (by machine translation)

-

Paragraph 0047; 0051; 0052, (2017/03/08)

The invention relates to a preparation N 2-phenylacetyl-D-guanylin improved method, to the three a-based silicon-based protection in-quanosine D, adding phenyllacetyl chloride, 1-hydroxy benzotriazole, acetonitrile and reaction solution of pyri

Some observations relating to the use of 1-aryl-4-alkoxypiperidin-4-yl groups for the protection of the 2′-hydroxy functions in the chemical synthesis of oligoribonucleotides

Lloyd, Wayne,Reese, Colin B.,Song, Quanlai,Vandersteen, Anthony M.,Visintin, Cristina,Zhang, Pei-Zhou

, p. 165 - 176 (2007/10/03)

The comparative rates of acid-catalysed removal often 1-aryl-4-methoxypiperidin-4-yl 8 (R = Me) [including the previously reported Ctmp 5 and Fpmp 6] protecting groups for the 2′-hydroxy functions in oligoribonucleotide synthesis are discussed. These studies have led to the development of the 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl (Cpep) protecting group 8 (R = Et, R1 = R2 = H, R3 = Cl) which is both more stable than the Ctmp and Fpmp groups at pH 0.5 and more labile at pH 3.75. The influence of the ribonucleoside aglycone on the stability of the 2′-O-Fpmp and 2′-O-Ctmp protecting groups both at low and high pH is examined. The Royal Society of Chemistry 2000.

Base-modified enzymatic nucleic acid

-

, (2008/06/13)

An enzymatic nucleic acid having a modification selected from pyridin-4-one, pyridin-2-one, phenyl, pseudouracil, 2, 4, 6-trimethoxy benzene, 3-methyluracil, dihydrouracil, naphthyl, 6-methyl-uracil and aminophenyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132628-16-1